{"resourceType": "Group", "meta": {"versionId": "9", "lastUpdated": "2025-03-15T21:01:03.463Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-comparator-definition"]}, "title": "ConceptualComparatorDefinition: Usual-care pharmacologic thromboprophylaxis", "status": "active", "url": "https://fevir.net/resources/Group/179785", "id": "179785", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "urn:ietf:rfc:3986", "value": "https://fevir.net/FOI/179785", "assigner": {"display": "Computable Publishing LLC"}}], "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Brian S. Alper"}}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as", "valueMarkdown": "ConceptualComparatorDefinition: Usual-care pharmacologic thromboprophylaxis [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179785. Revised 2024-12-27. Available at: https://fevir.net/resources/Group/179785. Computable resource at: https://fevir.net/resources/Group/179785#json."}], "membership": "conceptual", "combinationMethod": "any-of", "characteristic": [{"description": "ATTACC comparator arm", "code": {"text": "Defined by CodeableConcept"}, "valueCodeableConcept": {"text": "Standard venous thromboprophylaxis according to local guidelines or usual practice. Dose of chosen agent should not be more than half of the approved therapeutic dose for the treatment of venous thromboembolism."}, "exclude": false, "timing": [{"contextCode": {"text": "Start of trial"}, "offsetRange": {"low": {"value": 0}, "high": {"value": 14, "unit": "days", "system": "http://unitsofmeasure.org", "code": "d"}}, "text": "Up to 14 days or until hospital discharge, whichever comes first. After this period, decisions regarding thromboprophylaxis are at discretion of treating clinician."}]}, {"description": "ACTIV-4a comparator arm", "code": {"text": "Defined by CodeableConcept"}, "valueCodeableConcept": {"text": "Any one of enoxaparin, dalteparin, tinzaparin, fondaparinux, or heparin according to local preference. Dose of agent specified to be consistent with guidelines for low dose thromboprophylaxis."}, "exclude": false, "timing": [{"contextCode": {"text": "Start of trial"}, "offsetRange": {"low": {"value": 0}, "high": {"value": 14, "unit": "days", "system": "http://unitsofmeasure.org", "code": "d"}}, "text": "Up to 14 days or until hospital discharge, whichever comes first. After this period, decisions regarding thromboprophylaxis are at discretion of treating clinician."}]}, {"description": "REMAP-CAP comparator arm", "code": {"text": "Defined by CodeableConcept"}, "valueCodeableConcept": {"text": "Standard venous thromboprophylaxis according to local guidelines or usual practice. Dose of chosen agent should not be sufficient to result in therapeutic anticoagulation."}, "exclude": false, "timing": [{"contextCode": {"text": "Start of trial"}, "offsetRange": {"low": {"value": 0}, "high": {"value": 14, "unit": "days", "system": "http://unitsofmeasure.org", "code": "d"}}, "text": "Up to 14 days or until hospital discharge, whichever comes first. After this period, decisions regarding thromboprophylaxis are at discretion of treating clinician."}]}], "description": "Description: usual-care pharmacologic thromboprophylaxis\nNote: Thromboprophylaxis was provided at a dose and duration determined by the treating clinician according to local practice.\nNote: Usual-care pharmacological thromboprophylaxis included both intermediate-intensity (in 27%) and prophylactic-intensity dosing (in 72%). Subgroup analyses may be informative to determine if there is a difference related to the intensity used in the control arm of the trial.", "name": "ConceptualComparatorDefinition_Usual_care_pharmacologic_thromboprophylaxis", "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}}